Cardio-diabetology: New subspecialty and collaborative work to defeat the burden of deadly duo
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2018, Vol 5, Issue 4
Abstract
Cardiovascular disease (CVD) is one of the most global threatened diseases; particularly coronary artery disease (CAD) is a major deadly attack around the world. Diabetes mellitus (DM) is associated with a 2 to 4-fold increased mortality risk from heart disease. Diabetes related microvascular complication is seemed to be a hazardous factor for cardiovascular system and likely to cause coronary arteries disease, hypertension, peripheral arteries, and carotid vessels, especially seen in the type 2 DM populations. The severity of cardiovascular complications are related to prolong hyperglycemia and the control of dysglycemia. Thus, effective glycemic control is one of the imperative aspects of the management for the prevention of CVD in diabetes. In addition, different kinds of antidiabetes agents have different mechanism of actions that has impacted to cardiovascular outcome. The benefit and risk of current anti-diabetic agents are needed to define clearly and that is needed to promote effective clinical care between cardiology and diabetology. There are multiple complications and sequelae of diabetes that requires the involvement of cardiologic expertise in the diabetes care setting in heart disease population. Therefore, the close cooperation between the cardiologist and the diabetologist is new perceptive way of care to defeat diabetes related cardiovascular complications.
Authors and Affiliations
Tun HN
Keywords
Related Articles
- EP ID EP524025
- DOI 10.17352/2455-2976.000077
- Views 101
- Downloads 0
Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
Background: We compared the angiotensin receptor–neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. Methods: In this double-...
Hydrogels for Cardiac Tissue Repair and Regeneration
The main cause of death in the world continues to be cardiovascular disease, which affects annually over 900,000 people and in the entire word approximately 50% of the people suffering myocardial infarction (MI) die with...
The pathophysiology of chronic cardiorenal disease based on central hemodynamics
As patients with chronic kidney disease (CKD) and chronic heart failure (CHF) increase, there is concern about a future heart failure pandemic. Deterioration of renal function is an independent prognostic factor for CHF...
Reperfusion of Acute Myocardial Infarction in the elderly (clinical characteristics and prognosis) Results of the IMSS Nuevo León infarction code program
Background: The age is an important prognostic factor in patients with acute myocardial infarction. To find no similar data in the Mexican population, it seeks to establish the characteristics and prognosis of older adul...
An Updated Systematic Review and Meta-analysis of the Short- and Long-term Outcomes of Percutaneous Coronary Intervention for Patients with Severe Left Ventricular Systolic Dysfunction
Background: Coronary artery disease (CAD) is the most common cause of left ventricular dysfunction (LVD). Confl icting evidence exists with regards to available treatments and patient prognosis. Revascularization may imp...